NCT01078272

Brief Summary

This study tests the hypothesis that repeated inflation of a blood pressure cuff on the arm will improve results of coronary stent implantation by:

  • reducing chest pain and electrocardiogram changes during balloon inflation to place the stent
  • reducing leakage of heart muscle protein(troponin) into the blood stream after stent placement, indicated reduced damage to heart muscle during stent implantation
  • increases in molecules in the blood that promote dilation of arteries
  • reduced evidence of heart muscle damage on MRI immediately after stenting
  • improved patient outcomes over six months with fewer adverse cardiovascular events(heart attack, acute coronary syndrome,renarrowing of the stented artery, heart failure, death, stroke, transient ischemic attack)
  • improved heart structure and function at 6 months after stenting

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable coronary-artery-disease

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2010

Completed
Same day until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 2, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

March 19, 2020

Status Verified

March 1, 2020

Enrollment Period

1.6 years

First QC Date

March 1, 2010

Last Update Submit

March 17, 2020

Conditions

Keywords

Coronary AtherosclerosisPercutaneous Coronary InterventionCoronary StentingCoronary StenosisRemote Ischemic Preconditioning

Outcome Measures

Primary Outcomes (1)

  • MACE

    MACE is defined as a combined endpoint including: heart attack, acute coronary syndrome,restenosis of the stented artery, new heart failure stroke, transient ischemic attack or death

    6 months post-stenting

Secondary Outcomes (5)

  • troponin I

    24 hours

  • chest pain during stenting

    immediate during procedure

  • ST segment changes during stent implantation

    immediate

  • MRI delayed enhancement

    1-7 days after stenting

  • Late left ventricular volumes and ejection fraction

    6 months

Study Arms (2)

Remote Ischemic Preconditioning (RIPC)

EXPERIMENTAL

Randomized subjects who are treated immediately prior to stenting with remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff inflations to occlude the brachial artery in their nondominant arms, with intervening 5 minute rest periods.

Other: Remote ischemic preconditioning

Sham Remote Ischemic Preconditioning

PLACEBO COMPARATOR

Patients who prior to stenting have the RIPC blood pressure cuff placed but not inflated for 3 5 minute episodes with 5 minute rest periods.

Other: Sham Remote Ischemic Preconditioning

Interventions

Randomized subjects are treated immediately prior to stenting with remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff inflations to occlude the brachial artery in their nondominant arms, with intervening 5 minute rest periods.

Remote Ischemic Preconditioning (RIPC)

Randomized subjects who are exposed immediately prior to stenting to sham remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff placements without inflation on their nondominant arms, with intervening 5 minute rest periods.

Sham Remote Ischemic Preconditioning

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with stable chronic coronary artery disease scheduled for elective percutaneous intervention.

You may not qualify if:

  • Recent (1 month) myocardial infarction
  • Acute coronary syndrome
  • Chest pain at res
  • Estimated glomerular filtration rate(GFR)\<45 mL/min/1.73 m2
  • Frequent premature atrial or ventricular contractions or atrial fibrillation
  • Any contraindication to MRI including implanted non MRI compatible medical devices or ferromagnetic materials such as shrapnel
  • Inability to breath-hold
  • Severe claustrophobia
  • Deafness
  • Persistent tremor
  • Inability to follow instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Francis Hospital-The Heart Center

Roslyn, New York, 11576, United States

Location

Related Links

MeSH Terms

Conditions

Coronary Artery DiseaseCoronary Stenosis

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Nathaniel Reichek, MD

    St. Francis Hospital-The Heart Center, Roslyn, NY

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Research Department and Cardiac Imaging Program

Study Record Dates

First Submitted

March 1, 2010

First Posted

March 2, 2010

Study Start

March 1, 2010

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

March 19, 2020

Record last verified: 2020-03

Locations